As of Oct 21
| -0.09 / -0.61%|
The 4 analysts offering 12-month price forecasts for NewLink Genetics Corp have a median target of 17.00, with a high estimate of 23.00 and a low estimate of 10.00. The median estimate represents a +15.49% increase from the last price of 14.72.
The current consensus among 4 polled investment analysts is to Hold stock in NewLink Genetics Corp. This rating has held steady since October, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.